Eylea (VEGF Trap-eye) Approved by FDA
Eylea (VEGF Trap-eye) has been approved by the FDA. The drug achieves the same results as Lucentis but after a monthly injection for three months it is then injected every two months. Pricewise it is similar to Lucentis. The potential of achieving the same efficacy with less frequent injections and monitoring offers a cost savings to consumers as well as a time saving benefit.
If you found this article interesting, you can get updates in your email inbox any time similar articles are posted. The subscription options you will be presented with are based on your interest in this article. Just click here to sign up for a free membership and get started!